Source: Annual Congress 2008 - Should asthma no longer be considered an allergic disease?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
P. L. P. Brand (Zwolle, The Netherlands). The consequences of novel insights into the pathophysiology of asthma for its treatment. Annual Congress 2008 - Should asthma no longer be considered an allergic disease?

Member's Comments

No comment yet.

Related content which might interest you: COPD – will new insights into molecular pathology define new therapies? Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 COPD mechanisms: novel aspects and implications for new therapies Source: ERS Live 2007 Year: 2007 Clinical implications of the new concepts regarding COPD pathophysiology Source: Annual Congress 2008 - New insights into COPD pathophysiology Year: 2008 Asthma, COPD and SARS-CoV-2 infection (COVID-19): potential mechanistic insights Source: Eur Respir J, 58 (2) 2100920; 10.1183/13993003.00920-2021 Year: 2021 Mechanisms of COPD exacerbations - molecular perspectives and pathophysiology Source: ERS Satellites 2021 Year: 2021 Latest insights into treatment of small airways diseases Source: International Congress 2019 – PG12 Recent advances in small airways diseases in patients with asthma and COPD Year: 2019 The role of biomarkers in the management of severe asthma Source: International Congress 2019 – Severe asthma guidelines: update 2019 Year: 2019 New genetics and epigenetics insights in paediatric asthma Source: International Congress 2017 – Omics in paediatric asthma and beyond Year: 2017 Translational research approaches for finding new therapeutic targets involved in viral-induced asthma and COPD exacerbation Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Asthma attacks: pathogenesis and therapeutic implications Source: International Congress 2019 – New recommendations and priorities for asthma management Year: 2019 COVID-19 conundrum: clinical phenotyping based on pathophysiology as a promising approach to guide therapy in a novel illness Source: Eur Respir J, 56 (2) 2002135; 10.1183/13993003.02135-2020 Year: 2020 To the molecular genetic mechanisms of the COPD pathogenesis Source: International Congress 2018 – Functional genomics and COPD: new challenges Year: 2018 Current understanding of ARDS pathophysiology Source: Virtual Congress 2021 – Acute respiratory distress syndrome phenotypes: implications for diagnosis and treatment Year: 2021 New insights into the pathophysiology of difficult weaning Source: International Congress 2017 – Update on weaning from the ventilator Year: 2017 Does acute and persistent metabolic dysregulation in COVID-19 point to novel biomarkers and future therapeutic strategies? Source: Eur Respir J, 59 (2) 2102417; 10.1183/13993003.02417-2021 Year: 2022 Chronic cough: new insights and future prospects Source: Eur Respir Rev, 30 (162) 210127; 10.1183/16000617.0127-2021 Year: 2021 New insights into the pathophysiology of asthma Source: Annual Congress 2011 - PG6 Paediatric asthma: state of the art Year: 2011 IgE-mediated asthma: New revelations and future insights Source: International Congress 2015 – IgE-mediated asthma: New revelations and future insights Year: 2015